Non-Surgical Approach to Managing Hip Osteoarthritis At Pain Doctors Medical
Are You a Regenexx Candidate?This location is for evaluation appointments only.
Can Hip Pain from Osteoarthritis Be Addressed Without Surgery?
Non-surgical approaches for managing hip discomfort related to osteoarthritis are available through physicians in the licensed Regenexx network.
Discomfort is one of the most common symptoms associated with hip osteoarthritis, often occurring more frequently than joint stiffness or mobility limitations. When a physician suggests that joint replacement is the only path forward for hip discomfort caused by osteoarthritis, exploring less invasive alternatives may be beneficial.
Hip osteoarthritis develops as the cartilage surfaces within the joint gradually deteriorate. Interventional orthobiologic procedures may help support the body’s natural ability to reduce discomfort and may help improve joint function. These less invasive approaches may offer shorter recovery times and may carry fewer potential complications when compared to typical surgical interventions.
Patients seeking consultation for hip osteoarthritis in the New Jersey area may visit Pain Doctors Medical at 495 North 13th Street, Newark, New Jersey, a location in the licensed Regenexx network.
| Regenexx-SD | Surgery | |
|---|---|---|
| Return to Daily Routine | 2 to 5 days | 6+ weeks |
| Return to Sports | 3 to 6 months | 1 year |
| Recovery | Brace, up to 6 weeks PT | Crutches, brace, extensive, no driving, 3 to 6 months PT |
| Pain Management | Mostly over-the-counter pain medication (days) | Prescription pain medication for weeks (weeks) |
| General Anesthesia | No | Yes |
| Keep Your Hip Joint | Yes | No |
495 North 13th Street
Newark, NJ 07107
Request an Appointment
Call to Schedule Schedule OnlineClinic Hours
| Sunday | Closed |
| Monday | 9AM–5PM |
| Tuesday | 9AM–5PM |
| Wednesday | 9AM–5PM |
| Thursday | 9AM–5PM |
| Friday | 9AM–5PM |
| Saturday | Closed |
How Does Regenexx Work?
The Regenexx approach at Pain Doctors Medical is a form of interventional orthobiologics that offers an alternative to typical orthopedic surgery.
Procedures using the Regenexx SD injectate are performed by physicians in the licensed Regenexx network and use advanced image guidance to precisely place a patient’s own bone marrow concentrate into areas of the hip joint where tissue damage has been identified[2-3]. This concentrate contains cells that may support the body’s natural healing response.
The healing agents in the bone marrow concentrate may help support the repair process by promoting the potential growth of new tissue. This may aid in stabilizing the hip joint and may help improve function and mobility over time[4].
What Are the Risks of Hip Replacement Surgery and Other Treatments?
Hip replacement and hip resurfacing are considered invasive procedures that often involve extended recovery periods. This may affect activity levels and overall well-being.
Potential risks linked to these surgical interventions include:
- Anesthesia-related complications, such as stroke or heart attack.
- Infection and blood clots.
- Prosthetic part failure and allergic reactions to metal components.
Furthermore, joint replacements may not be permanent and could necessitate revision procedures over time[5-6]. A 2016 meta-analysis of 17 clinical trials found no statistically significant improvement in physical activity levels for up to one year following a unilateral primary total hip replacement.
Pain management strategies also carry potential risks. Nonsteroidal anti-inflammatory drugs (NSAIDs) have been associated with an increased risk of cardiovascular events, while opioid use carries a high potential for dependence. Additionally, steroid injections may lead to undesirable side effects[7-10].
For those looking to avoid the potential risks associated with typical surgical treatments or long-term medication use, physicians in the licensed Regenexx network offer alternative procedures. These interventional orthobiologic procedures are designed to support the body’s natural healing mechanisms without the need for invasive surgery.
The Regenexx Approach for Hip Pain
Physicians in the licensed Regenexx network take a comprehensive and customized approach to evaluating hip discomfort.
During an initial visit, the physician may assess joint function in motion and use diagnostic ultrasound to view the structures of the hip in real time. This process helps identify the underlying factors contributing to discomfort and limitations in mobility.
Following this thorough evaluation, the physician develops a customized treatment plan specific to the patient’s condition and needs. Depending on the findings, the plan may utilize one or more of the following Regenexx injectates:
- Regenexx SD Injectate: Prepared using proprietary treatment protocols involving Bone Marrow Concentrate (BMC), which contains the patient’s own cellular healing agents.
- Regenexx SCP Injectate: A proprietary, lab-processed formulation of Platelet-Rich Plasma (PRP) that contains a higher concentration of growth factors compared to typical PRP preparations.
- Regenexx PL Injectate: A specialized derivative of PRP known as platelet lysate (PL), which is designed for a faster and more targeted release of growth factors.
These procedures utilize proprietary Regenexx processing methods and interventional orthobiologics. They are intended to support the body’s natural healing mechanisms, offering a non-surgical alternative for addressing hip discomfort.
Patients interested in a thorough evaluation of their hip condition may consult with a physician at Pain Doctors Medical, 495 North 13th Street, Newark, New Jersey, a location in the licensed Regenexx network.
Webinar: Addressing Hip Pain from Osteoarthritis Without Surgery
Join Chris Centeno, M.D., founder of Regenexx, for a free educational webinar exploring how procedures using Regenexx lab processes may offer a non-surgical option for managing hip pain caused by osteoarthritis.
In this webinar, patients will learn:
- How procedures using bone marrow concentrate and platelet-rich plasma (PRP) may compare to typical surgical options and other interventions
- What to expect during and after procedures using Regenexx injectates
- Answers to frequently asked questions about interventional orthobiologics and Regenexx’s proprietary methods
FAQs
Hip osteoarthritis involves the gradual breakdown of cartilage and other joint tissues, which can lead to reduced mobility and joint function. This condition may develop due to factors such as prior injury, inflammatory conditions, genetic predisposition, joint infections, or cumulative wear over time.
While hip arthritis is more commonly diagnosed in individuals in their 60s and 70s, the age of onset can vary based on factors such as physical activity, body weight, and individual joint anatomy.
Not always. In the early stages, hip arthritis may present as stiffness or reduced range of motion rather than pain. As the joint continues to degenerate over time, discomfort or pain often becomes more noticeable.
Yes, MRI imaging can typically reveal degenerative changes in the hip joint. In the video below, Chris Centeno, M.D., highlights three key signs of hip arthritis commonly seen on MRI scans.
At first glance, hip resurfacing may seem less invasive, which often leads people to believe it carries fewer risks. However, that is not always the case. In a conventional hip replacement, both the ball and socket of the joint are removed and replaced with artificial components made from metal, ceramic, or a combination of materials. The stem of the implant is inserted into the marrow space of the femur (thighbone).
In contrast, hip resurfacing preserves more of the natural bone. Rather than removing the ball of the femur, it is reshaped so that a metal covering can be placed over it. While this approach maintains more of the thighbone and is often considered less invasive, studies have shown it may be associated with a higher risk of thigh fractures, larger surgical incisions, pseudotumors, earlier prosthesis failure, and the potential for metal particles to enter the bloodstream due to metal-on-metal implant surfaces.¹¹⁻¹²
Get started to see if you are a Regenexx candidate
To talk one-on-one with one of our team members about how the Regenexx approach may be able to help your orthopedic pain or injury, please complete the form below and we will be in touch with you within the next business day.
References
1. Trouvin AP, Perrot S. Pain in osteoarthritis. Implications for optimal management. Joint Bone Spine. 2018 Jul;85(4):429-434. doi: 10.1016/j.jbspin.2017.08.002. Epub 2017 Sep 6. PMID: 28889010. Sep 6. PMID: 28889010.
2. Centeno CJ. Efficacy and Safety of Bone Marrow Concentrate for Osteoarthritis of the Hip; Treatment Registry Results for 196 Patients. J Stem Cell Res Ther 2014;04(10). doi:10.4172/2157-7633.1000242.
3. Friedlis MF, Centeno CJ. Performing a Better Bone Marrow Aspiration. Phys Med Rehabil Clin N Am. 2016 Nov;27(4):919-939. doi: 10.1016/j.pmr.2016.06.009. PMID: 27788908.
4. Centeno CJ, Kisiday J, Freeman M, Schultz JR. Partial regeneration of the human hip via autologous bone marrow nucleated cell transfer: A case study. Pain Physician. 2006 Jul;9(3):253-6.
5. Lalmohamed A, Vestergaard P, Cooper C, de Boer A, Leufkens HG, van Staa TP, de Vries F. Timing of stroke in patients undergoing total hip replacement and matched controls: a nationwide cohort study. Stroke. 2012 Dec;43(12):3225-9. doi: 10.1161/STROKEAHA.112.668509. Epub 2012 Nov 6. PMID: 23132782.
6. Harding P, Holland AE, Delany C, Hinman RS. Do activity levels increase after total hip and knee arthroplasty? Clin Orthop Relat Res. 2014 May;472(5):1502-11. doi: 10.1007/s11999-013-3427-3. Epub 2013 Dec 19. PMID: 24353051; PMCID: PMC3971219.
7. How long does a hip replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up Evans JT, Evans JP, Walker RW, Blom AW, Whitehouse MR, Sayers A. How long does a hip replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up. Lancet. 2019;393(10172):647-654. doi:10.1016/S0140-6736(18)31665-9
8. Withers TM, Lister S, Sackley C, Clark A, Smith TO. Is there a difference in physical activity levels in patients before and up to one year after unilateral total hip replacement? A systematic review and meta-analysis. Clin Rehabil. 2017;31(5):639-650. doi:10.1177/0269215516673884
9. Sakaguchi M, Tanaka T, Fukushima W, Kubo T, Hirota Y; Idiopathic ONF Multicenter Case-Control Study Group. Impact of oral corticosteroid use for idiopathic osteonecrosis of the femoral head: a nationwide multicenter case-control study in Japan. J Orthop Sci. 2010;15(2):185-191. doi:10.1007/s00776-009-1439-3
10. Ravi B, Escott BG, Wasserstein D, et al. Intraarticular hip injection and early revision surgery following total hip arthroplasty: a retrospective cohort study. Arthritis Rheumatol. 2015;67(1):162-168. doi:10.1002/art.38886
11. Hjorth MH, Mechlenburg I, Soballe K, et al. Higher prevalence of mixed or solid pseudotumors in metal-on-polyethylene total hip arthroplasty compared with metal-on-metal total hip arthroplasty and resurfacing hip arthroplasty. J Arthroplasty, 2018;33:2279–2286. doi:10.1016/j.arth.2018.02.011.
12. Oxblom A, Hedlund H, Nemes S, et al. Patient-reported outcomes in hip resurfacing versus conventional total hip arthroplasty: a register-based matched cohort study of 726 patients. Acta Orthop. 2019;90:318-323. doi:10.1080/17453674.2019.1604343.
